0001209191-23-028114.txt : 20230508 0001209191-23-028114.hdr.sgml : 20230508 20230508200945 ACCESSION NUMBER: 0001209191-23-028114 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230504 FILED AS OF DATE: 20230508 DATE AS OF CHANGE: 20230508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gibson Daniel Glenn CENTRAL INDEX KEY: 0001866133 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40497 FILM NUMBER: 23899581 MAIL ADDRESS: STREET 1: C/O CODEX DNA, INC. STREET 2: 9535 WAPLES STREET, SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Telesis Bio Inc. CENTRAL INDEX KEY: 0001850079 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 451216839 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9535 WAPLES STREET STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-228-4115 MAIL ADDRESS: STREET 1: 9535 WAPLES STREET STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Codex DNA, Inc. DATE OF NAME CHANGE: 20210309 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-04 0 0001850079 Telesis Bio Inc. TBIO 0001866133 Gibson Daniel Glenn C/O CODEX DNA, INC. 10431 WATERIDGE CIRCLE, SUITE 150 SAN DIEGO CA 92121 0 1 0 0 Chief Technology Officer 0 Common Stock 2023-05-04 4 S 0 1190 2.8261 D 102083 D Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") and does not represent a discretionary sale by the Reporting Person. Represents the weighted average share price of shares sold in the price range of $2.75 to $2.925 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. The reporting person has reported a prior award of RSUs in Table II of Form 4. The total reported in Column 5 includes the 20,910 RSUs previously reported in Table II, and 81,173 shares of common stock. /s/ Rob Cutler, as Attorney-in-Fact 2023-05-08